April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Hyaluronan Complex Purified From Human Amniotic Membrane Extract Inhibits Proliferation of Endothelial Cells (HUVEC) and Macrophages (RAW264.7)
Author Affiliations & Notes
  • E. Shay
    TissueTech Inc, Miami, Florida
  • H. He
    TissueTech Inc, Miami, Florida
  • S. Zhang
    TissueTech Inc, Miami, Florida
  • S. C. G. Tseng
    TissueTech Inc, Miami, Florida
  • Footnotes
    Commercial Relationships  E. Shay, Tissue Tech, Inc., E; H. He, Tissue Tech, Inc., E; S. Zhang, Tissue Tech, Inc., E; S.C.G. Tseng, Tissue Tech, Inc., I; Tissue Tech, Inc., P.
  • Footnotes
    Support  : NIH, NEI R43 EY017497 (to SCGT)
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5560. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Shay, H. He, S. Zhang, S. C. G. Tseng; Hyaluronan Complex Purified From Human Amniotic Membrane Extract Inhibits Proliferation of Endothelial Cells (HUVEC) and Macrophages (RAW264.7). Invest. Ophthalmol. Vis. Sci. 2009;50(13):5560.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Amniotic membrane (AM) and its extract (AME) have anti-angiogenic and anti-inflammatory actions. We speculate that hyaluronan (HA) complex such as HC-HA (the heavy chain (HC) of inter--trypsin inhibitor (II) complexed with HA) contributes to these effects and sought to purify and characterize this complex from AME.

Methods: : AME was obtained from AM extracted in PBS. Subsequently, H fraction, which contains HC-HA complex, was purified from AME by two rounds of ultracentrifugation with CsCl/4M guanidine. The purity of H fraction was examined by SDS-PAGE with Coomassie blue staining. The size and quantity of HA in H fraction was determined by agarose gel electrophoresis followed by staining with Stains-All dye.HC-HA complex in H fraction was demonstrated by treatment of H fraction with hyaluronidase (HAase) or 0.05 N NaOH followed by Western blotting with anti-II antibody. The effects of H fraction on cell morphology and proliferation of HUVEC and RAW264.7 were shown by phalloidin staining, MTT assay, and BrdU labeling/staining.

Results: : H fraction contains very little protein based on Coomassie blue staining. HA in H fraction was high molecular weight (> 6000-kDa) and covalently linked with HC, which was released from HA after HAase digestion or NaOH treatment. Inclusion of H fraction in the medium significantly reduced filamentous actin, and significantly suppressed proliferation in HUVEC using MTT assay (from 0.28 ± 0.02 to 0.11 ± 0.02, p=0.0004) and in RAW264.7 cells (from 0.82 ± 0.13 to 0.43 ± 0.04, p=0.0002). BrdU labeling and staining further confirmed such suppression in HUVEC (from 0.32±0.04 to 0.02±0.03, p=0.00005) and in RAW264.7 cells (p=0.03).

Conclusions: : HC-HA complex in H fraction was a potential factor contributing to suppressing activation and proliferation in HUVEC and macrophages. These effects explain, at least partially, AM’s activity against angiogenesis and inflammation.

Keywords: neovascularization • proliferation • phosphorylation 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.